On Blarcamesine for Alzheimer Disease, With Christopher Missling, PhDByChristopher Missling, PhDSeptember 12th 2025Discover how blarcamesine, a novel therapy for Alzheimer disease, shows promise in preventing cognitive decline and enhancing patient quality of life.